Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Surface Logix Completes $25M Round For Drug Discovery Work

Nov. 27, 2002

By Aaron Lorenzo

Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft

Nov. 26, 2002

By Aaron Lorenzo

Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft

Nov. 26, 2002

By Aaron Lorenzo

Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis

Nov. 22, 2002

By Aaron Lorenzo

Inflazyme In Line For Up To $90M After Expanding Deal With Aventis

Nov. 22, 2002

By Aaron Lorenzo

Inflazyme In Line For Up To $90M After Expanding Deal With Aventis

Nov. 22, 2002

By Aaron Lorenzo

Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis

Nov. 22, 2002

By Aaron Lorenzo

Palatin Raises $11.5M For LeuTech, PT-141 Progress

Nov. 21, 2002

By Aaron Lorenzo

Palatin Raises $11.5M For LeuTech, PT-141 Progress

Nov. 21, 2002

By Aaron Lorenzo

Psychiatric Genomics Raises $17M As Part Of Series B Round

Nov. 20, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...